General description
Immunoglobulin therapy, also known as normal human immunoglobulin (NHIG), is the use of a mixture of antibodies (immunoglobulins) to treat primary immunodeficiency and Kawasaki disease.
ATC codes
Medicine type
Biological agent
EML status history
First added in 1977
(TRS
615)
for
Primary immunodeficiencies
Added in 1977
(TRS
615)
for
Mucocutaneous lymph node syndrome
Removed in 2003
(TRS
920)
for
Primary immunodeficiencies
Removed in 2003
(TRS
920)
for
Mucocutaneous lymph node syndrome
Added in 2007
(TRS
946)
for
Primary immunodeficiencies
Added in 2007
(TRS
946)
for
Mucocutaneous lymph node syndrome
Added in 2023
(TRS
1049)
for
Langerhans cell histiocytosis
Wikipedia
Recommendations
Section
Human immunoglobulins
- Parenteral > General injections > IV: 5% protein solution; 10% protein solution
- Parenteral > General injections > IM: 16% protein solution
- Parenteral > General injections > SC: 15% protein solution; 16% protein solution